| Title | Author(s) | Year | View Count |  | HBsAg-HBIg complex modulates antigen presentation of dendritic cells from chronic hepatitis B patients | Zheng, B; Yao, X; Zhou, J; Wen, YM | 2009 | 433 |
 | Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systems | Chen, JY; Chen, WN; Poon, KMV; Zheng, BJ; Lin, X; Wang, YX; Wen, YM | 2009 | 569 |
 | The Y271 and I274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability | Zhang, HJ; Wang, YX; Wu, H; Jin, DY; Wen, YM; Zheng, BJ | 2009 | 103 |
 | Mutations of the turn between helix H and I of HIV-1 reverse
transcriptase affect RT incorporation into viral particles and
subsequent viral replication | Zhang, H; Wang, YX; Wu, H; Zhang, Q; Wen, YM; Zheng, B | 2008 | 146 |
 | Mutational analysis of the "turn" of helix clamp motif of HIV-1 reverse transcriptase | Wang, YX; Zhang, HJ; Xu, J; Zheng, BJ; Wen, YM | 2008 | 63 |
 | Turn residue at the helix clamp motif of reverse transcriptase is crucial for replication for both hepatitis B virus and human immunodeficiency virus | Wang, YX; Zhang, H; Xu, J; Wen, YM; Zheng, B | 2007 | 126 |
 | Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients | Yao, X; Zheng, B; Zhou, J; Xu, DZ; Zhao, K; Sun, SH; Yuan, ZH; Wen, YM | 2007 | 70 |
 | Hepatitis B surface antigen-antibody complex reverted immune tolerance in chronic hepatitis B patients via modulating dendritic cells. | Yao, X; Zheng, B; Zhou, J; Xu, DZ; Zhao, K; Sun, SH; Yuan, ZH; Wen, YM | 2007 | 120 |
 | Polymorphisms in the type I interferon receptor I promoter affect its transcriptional activity and susceptibility to chronic HBV infection. | Zhou, J; Lu, L; Poon, KM; Wu, HW; Ng, F; Chan, CS; Wen, YM; Zheng, B | 2006 | 108 |
 | Interferon receptor 1 promoter polymorphisms and susceptibility to chronic hepatitis B virus infection. | Zhou, J; Wu, HW; Poon, KM; Ng, F; Chan, CS; Qu, D; Wen, YM; Lu, L; Zheng, B | 2006 | 110 |
 | IFNAR1 promoter polymorphisms associated with susceptibility to chronic HBV infection and functional implication. | Zheng, B; Zhou, J; Wu, HW; Poon, KM; Ng, F; Chan, CS; Lu, L; Wen, YM | 2006 | 107 |
 | Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice | Qu, D; Zheng, B; Yao, X; Guan, Y; Yuan, ZH; Zhong, NS; Lu, LW; Xie, JP; Wen, YM | 2005 | 131 |
 | Selective functional deficit in dendritic cell - T cell interaction is a crucial mechanism in chronic hepatitis B virus infection | Zheng, BJ; Zhou, J; Qu, D; Siu, KL; Lam, TW; Lo, HY; Lee, SS; Wen, YM | 2004 | 155 |
 | High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation | Lau, GKK; Leung, YH; Fong, DYT; Au, WY; Kwong, YL; Lie, A; Hou, JL; Wen, YM; Nanj, A; Liang, R | 2002 | 158 |
 | Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice | Zheng, B; Ng, MH; He, LF; Yao, X; Chan, KW; Yuen, KY; Wen, YM | 2001 | 77 |
|